192 related articles for article (PubMed ID: 33115414)
21. Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Mao J; Chen N; Zhang S; Fang Y; Zheng Z; Wu S; Ye X; Chen Y; Chen Y; Shen L
Front Med (Lausanne); 2022; 9():973025. PubMed ID: 36213652
[TBL] [Abstract][Full Text] [Related]
22. Evidence for Activation of Lectin and Classical Pathway Complement Components in Aqueous Humor of Neovascular Age-Related Macular Degeneration.
Omori T; Oguchi Y; Machida T; Kato Y; Ishida Y; Ojima A; Itagaki K; Shintake H; Tomita R; Kasai A; Sugano Y; Ogasawara M; Sekine H; Sekiryu T
Ophthalmic Res; 2020; 63(3):252-258. PubMed ID: 31645047
[TBL] [Abstract][Full Text] [Related]
23. Changes in multiple cytokine concentrations in the aqueous humour of neovascular age-related macular degeneration after 2 months of ranibizumab therapy.
Sakamoto S; Takahashi H; Tan X; Inoue Y; Nomura Y; Arai Y; Fujino Y; Kawashima H; Yanagi Y
Br J Ophthalmol; 2018 Apr; 102(4):448-454. PubMed ID: 28765149
[TBL] [Abstract][Full Text] [Related]
24. Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration.
Zhu J; Su T; Wang M; Li M; Liu L; Wang F
Semin Ophthalmol; 2021 Feb; 36(1-2):9-13. PubMed ID: 33587673
[No Abstract] [Full Text] [Related]
25. ANGIOPOIETIN-LIKE 4 CORRELATES WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kim JH; Shin JP; Kim IT; Park DH
Retina; 2018 Mar; 38(3):523-530. PubMed ID: 28151839
[TBL] [Abstract][Full Text] [Related]
26. Aqueous cytokine and growth factor levels indicate response to ranibizumab for diabetic macular oedema.
Shimura M; Yasuda K; Motohashi R; Kotake O; Noma H
Br J Ophthalmol; 2017 Nov; 101(11):1518-1523. PubMed ID: 28270488
[TBL] [Abstract][Full Text] [Related]
27. Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data.
Korobelnik JF; Delcourt C; Creuzot-Garcher C; Melaine A; Chassetuillier J; Lejeune A; Bénard S; Dupont-Benjamin L
J Med Econ; 2021; 24(1):1087-1097. PubMed ID: 34420480
[TBL] [Abstract][Full Text] [Related]
28. Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Shintake H; Tomita R; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Machida T; Sekine H; Sekiryu T
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):39. PubMed ID: 33252634
[TBL] [Abstract][Full Text] [Related]
29. Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy.
Zhou H; Zhao X; Wang S; Chen Y
Ophthalmol Ther; 2023 Apr; 12(2):827-837. PubMed ID: 36539596
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.
Muether PS; Hermann MM; Viebahn U; Kirchhof B; Fauser S
Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670
[TBL] [Abstract][Full Text] [Related]
31. Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times.
Fauser S; Muether PS
Br J Ophthalmol; 2016 Nov; 100(11):1494-1498. PubMed ID: 26888975
[TBL] [Abstract][Full Text] [Related]
32. The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema.
Lim SW; Bandala-Sanchez E; Kolic M; Rogers SL; McAuley AK; Lim LL; Wickremasinghe SS
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5382-5390. PubMed ID: 30452591
[TBL] [Abstract][Full Text] [Related]
33. Aqueous humor cytokine profiling in patients with wet AMD.
Liu F; Ding X; Yang Y; Li J; Tang M; Yuan M; Hu A; Zhan Z; Li Z; Lu L
Mol Vis; 2016; 22():352-61. PubMed ID: 27122966
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.
Cui W; Sun XY; Sun LP; Li J; Liu ZL; Zhang H
J Ocul Pharmacol Ther; 2021; 37(1):52-59. PubMed ID: 33216685
[No Abstract] [Full Text] [Related]
35. Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Gune S; Abdelfattah NS; Karamat A; Balasubramanian S; Marion KM; Morgenthien E; Sadda SR
Ophthalmology; 2020 Apr; 127(4):523-532. PubMed ID: 31718842
[TBL] [Abstract][Full Text] [Related]
36. Long-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes.
Spooner K; Fraser-Bell S; Hong T; Phan L; Wong JG; Chang A
Ophthalmol Retina; 2021 Jun; 5(6):511-518. PubMed ID: 33007523
[TBL] [Abstract][Full Text] [Related]
37. Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.
Despreaux R; Cohen SY; Semoun O; Zambrowski O; Jung C; Oubraham H; Souied EH
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):639-44. PubMed ID: 26092633
[TBL] [Abstract][Full Text] [Related]
38. HTRA1 and TGF-β1 Concentrations in the Aqueous Humor of Patients With Neovascular Age-Related Macular Degeneration.
Tosi GM; Caldi E; Neri G; Nuti E; Marigliani D; Baiocchi S; Traversi C; Cevenini G; Tarantello A; Fusco F; Nardi F; Orlandini M; Galvagni F
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):162-167. PubMed ID: 28114575
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Aqueous Flare Levels Following Intravitreal Ranibizumab Injection for Neovascular Age-related Macular Degeneration.
Uzun A; Yalcindag FN; Demirel S; Batýoðlu F; Ozmert E
Ocul Immunol Inflamm; 2017 Apr; 25(2):229-232. PubMed ID: 26828124
[TBL] [Abstract][Full Text] [Related]
40. Onset of Retinal Pigment Epithelium Atrophy Subsequent to Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration.
Sitnilska V; Altay L; Enders P; Hermann M; Muether PS; Fauser S
Ophthalmologica; 2019; 241(3):154-160. PubMed ID: 30304737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
